Deferred Sanctions Leave Hope For Takeda In Actos MDL
A Louisiana federal judge's scathing criticism of Takeda Pharmaceuticals America Inc.'s document destruction threatens to cripple Takeda's odds in thousands of cases in multidistrict litigation over its diabetes drug, but attorneys...To view the full article, register now.
Already a subscriber? Click here to view full article